No statistically significant differences in PFS occurred between bevacizumab and linifanib doses ( low , hazard ratio [ HR ] , 1.453 [ 95 % confidence interval [ CI ] , 0.830-2 .539 ] ; high , HR , 1.257 [ 95 % CI , 0.672-2 .351 ] ) .